Search clinical trials for: Breast cancer (BRCA) 2
Total 125590 results
-
Fondazione Policlinico Universitario Agostino Gemelli...Completed
-
Georgetown UniversityCompleted
-
Women's College HospitalCanadian Institutes of Health Research (CIHR); London Health Sciences Centre; H. Lee Moffitt Cancer Center and Research Institute and other collaboratorsUnknownBreast Cancer | Ovarian Cancer | BRCA1 Gene Mutation | BRCA2 Gene MutationCanada
-
The First Affiliated Hospital with Nanjing Medical...Jiangsu HengRui Medicine Co., Ltd.RecruitingTNBC - Triple-Negative Breast CancerChina
-
Akdeniz UniversityRecruiting
-
AstraZenecaBritish Columbia Cancer AgencyCompleted
-
Cynvenio BiosystemsUnknownTriple Negative Breast Cancer | BRCA Mutation | Natural Killer CellsUnited States
-
Hadassah Medical OrganizationUnknownBRCA1 Gene Mutation | BRCA2 Gene MutationIsrael
-
Tesaro, Inc.European Organisation for Research and Treatment of Cancer - EORTC; Breast... and other collaboratorsTerminatedOvarian Neoplasms | BRCA1 Gene Mutation | BRCA2 Gene Mutation | Neoplasms, Breast | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Carcinoma of BreastUnited States, Spain, Belgium, Israel, United Kingdom, Italy, Poland, Canada, Hungary, Netherlands, France, Portugal, Greece, Iceland
-
AstraZenecaCompletedRelapsed Ovarian Cancer, BRCA Mutation, Platinum SensitivityUnited States, Canada
-
AstraZenecaCompletedOvarian CancerBrazil, Panama, Colombia, Argentina, Mexico, Peru
-
Azienda Socio Sanitaria Territoriale degli Spedali...RecruitingSexual Dysfunction | Sexual Dysfunctions, Psychological | Sexual Dysfunction, Physiological | BRCA MutationItaly
-
National Cancer Institute (NCI)CompletedBRCA1 Gene | BRCA2 GeneUnited States
-
Chugai PharmaceuticalJapan Lung Cancer SocietyCompletedNon-small Cell Lung Cancer | Extensive Disease Small Cell Lung CancerJapan
-
National Cancer Institute (NCI)Completed
-
HKGepitherapeuticsKazakh Research Institute of Oncology & Radiology; Montreal EpiTerapia Inc.; Canada-Kazakhstan...TerminatedBreast Cancer | Breast Cancer FemaleKazakhstan
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingTreatment in HER2-negative Metastatic Breast Cancer Patients With Germline BRCA MutationChina
-
Johns Hopkins UniversityNational Cancer Institute (NCI); Lustgarten FoundationCompletedPancreatic Neoplasm | Peutz-Jeghers SyndromeUnited States
-
Dana-Farber Cancer InstituteIncyte CorporationCompletedMetastatic Breast Cancer | Recurrent Breast CancerUnited States
-
Columbia UniversityAmerican Cancer Society, Inc.CompletedBreast Cancer | Ovarian Cancer | BRCA1 Mutation | BRCA2 MutationUnited States
-
Tango Therapeutics, Inc.RecruitingBreast Cancer | Ovarian Cancer | Prostate Cancer | Pancreas Cancer | BRCA1 Mutation | BRCA-Mutated Ovarian Carcinoma | BRCA-Associated Breast Carcinoma | HRD Positive Advanced Ovarian CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNational Institutes of Health (NIH)Completed
-
AstraZenecaActive, not recruitingMetastatic Triple Negative Breast CancerUnited States, Belgium, Italy, Spain, United Kingdom, Canada, Czechia, Poland, France, Korea, Republic of, Germany, Taiwan, Portugal, Netherlands, Ireland
-
Dana-Farber Cancer InstituteActive, not recruiting
-
Chugai PharmaceuticalJapan Lung Cancer SocietyCompletedNon-small Cell Lung Cancer | Extensive Disease Small Cell Lung CancerJapan
-
PfizerActive, not recruitingOvarian Cancer | NSCLC | Solid Tumors | Urothelial Cancer | Advanced MalignanciesHungary, Spain, United States, Canada, Taiwan, Japan, Serbia, Italy, New Zealand, Australia, Mexico, Russian Federation, United Kingdom, France, Korea, Republic of, Belgium, Poland, Denmark, Israel
-
Zai Lab (Shanghai) Co., Ltd.Completed
-
New York Presbyterian HospitalWomen At RiskUnknown
-
Queen Mary University of LondonHoffmann-La RocheRecruitingUrogenital CancerUnited Kingdom
-
Monica MitaMerck Sharp & Dohme LLCRecruitingBreast CancerUnited States
-
National Cancer Institute, NaplesRecruiting
-
Dana-Farber Cancer InstituteGenentech, Inc.Active, not recruitingBreast Cancer | Stage II Breast Cancer | HER-2 Positive Breast Cancer | Stage III Breast CancerUnited States
-
MedSIRGlaxoSmithKlineCompletedBreast Cancer | Breast Cancer MetastaticSpain
-
Shaare Zedek Medical CenterNot yet recruitingHot Flashes | Menopause SurgicalIsrael
-
Rabin Medical CenterCompletedBRCA1 Gene Mutation | BRCA2 Gene MutationIsrael
-
Vifor Pharma, Inc.RecruitingHyperkalemiaUnited States, Israel
-
Davidzon, Guido, M.D.Weston Havens FoundationRecruiting
-
National Cancer Institute (NCI)CompletedBreast Neoplasm | Hereditary Neoplastic SyndromeUnited States
-
Spanish Breast Cancer Research GroupAstraZenecaCompleted
-
Toronto Sunnybrook Regional Cancer CentreSunnybrook Health Sciences Centre; Women's College HospitalRecruiting
-
ARCAGY/ GINECO GROUPAstraZenecaCompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CancerFrance
-
Stanford UniversityRecruitingVentral Hernia | Abdominoplasty | Panniculus | Flap ReconstructionUnited States
-
Aga Khan University Hospital, PakistanCompletedBreast Cancer | Genetic Predisposition | BRCA Mutation | Occult CancerPakistan
-
ARCAGY/ GINECO GROUPRecruitingOvarian CancerJapan, France
-
Invibio LtdNGMedical GmbHRecruitingCervical Disc DegenerationGermany
-
Merrimack PharmaceuticalsCompletedHER-2 Gene AmplificationUnited States
-
Yonsei UniversityEnrolling by invitationPlatinum-sensitive Recurrent BRCA Wild Type Ovarian CancerKorea, Republic of
-
Gazi UniversityHacettepe University; Cukurova University; Marmara University; Istanbul University and other collaboratorsUnknownEnteral Nutrition | Feeding Intolerance | Intestinal Fatty Acid Binding ProteinGermany
-
Hacettepe UniversityCompletedQuality of Life | Physical Disability | Psychosocial Problem | Meniere DiseaseTurkey
-
Ningbo No.2 HospitalNot yet recruitingCarcinoma, Non-Small-Cell Lung